Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs
批准号:
8602847
负责人:
PAUL L DEANGELIS
金额:
$38.15万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-12-15 至 2016-12-31
关键词:
AcetylationAcidsAnabolismBinding ProteinsBiochemicalBiochemistryBiologicalBiological AssayBiological ProcessBiologyBlood Coagulation FactorBypassCatabolismCell Culture TechniquesCell ProliferationCellsCoagulation ProcessComplexDevelopmentDisaccharidesDiseaseEmbryonic DevelopmentEngineeringEnzymesEventExhibitsFGF1 geneFibroblast Growth FactorFibroblast Growth Factor ReceptorsGlycoconjugatesGlycoproteinsGoalsGolgi ApparatusGrantGrowth FactorGrowth Factor ReceptorsGrowth and Development functionHealthHemostatic functionHeparan Sulfate BiosynthesisHeparinHeparitin SulfateHuman bodyIn VitroIndividualInorganic SulfatesIsomerismKnock-outLabelLearningLengthLibrariesLinkMalignant NeoplasmsMammalsMapsMass Spectrum AnalysisMeasuresMediatingMethodologyMethodsModelingModificationN DomainNuclear Magnetic ResonanceOligosaccharidesPatternPharmaceutical PreparationsPlayPolymersPolysaccharidesProtein IsoformsProteinsReceptor SignalingRecombinantsReportingRoleRouteSeriesSignal TransductionSpecificityStagingStructureStructure-Activity RelationshipSurface Plasmon ResonanceSystemTestingTherapeuticTransgenic OrganismsUnspecified or Sulfate Ion SulfatesUridine Diphosphate SugarsVariantVertebral columnamino groupanalogbasebiological systemscell growthcombinatorialcytokinedesigndomain mappingenzyme activityepimeraseextracellularheparanaseheparosan synthasehigh throughput screeningimprovedin vivomilligramnext generationpreferencereceptorresearch studysugarsulfated polymersulfationsulfotransferase
中文摘要
描述(由申请人提供):硫酸肝素(HS)是一类多糖,包括众所周知的药物肝素,在细胞生长和发育中起重要作用。在哺乳动物中观察到的许多HS结构变异被假设为不同地调节生长因子介导的信号传导并调节健康和疾病期间的止血。我们的项目将探索HS结构变化是如何在生物合成/分解代谢过程中产生的,并绘制路线,以制备具有更大选择性和更有效的生物活性的更明确的分子。一个受欢迎的假设是模式
英文摘要
DESCRIPTION (provided by applicant): Heparan sulfate (HS), a class of polysaccharides that includes the well-known drug heparin, plays essential roles in cell growth and development. The many structural variants of HS observed in mammals have been hypothesized to differentially modulate growth factor-mediated signaling and regulate hemostasis during health and disease. Our project will explore how the HS structural variation is generated during biosynthesis/catabolism as well as map routes to prepare more defined molecules having greater selectivity and more potent desired bioactivities. A favored hypothesis is that the pattern
of HS domains (comprised of both N-sulfo (NS) and N-acetyl (NA) domains) encodes information that modulates HS interaction with proteins like growth factors, cytokines, and clotting factors. Currently, it is very difficult to understand how HS biosynthetic modification an domain placement is controlled and which HS domain structures possess the highest activities in different biological systems. We will apply our newly developed synthetic methodology to answer key questions in the field. A small library of HS polymers having size-defined and placement-defined NS and NA domains will be generated. These HS polymers will then be modified by biosynthetic enzymes, including O-sulfotransferases, and C5-epimerase and/or catabolic enzymes including endo-6- Oendosulfatases and heparanase. A focused combinatorial approach will be used to produce defined HS polymers to test two opposing models of growth factor signaling, a key event in cell proliferation, embryonic development, and cancer. In this project our specific aims are: Aim 1: To chemoenzymatically synthesize a small library of HS polymers having defined NS and NA domains. Aim 2. To analyze the modification patterns generated through the action of various enzymes on the HS polysaccharide library. Aim 3: To characterize the structure/function relationship of HS activity as the co-receptor fibroblast
growth factor receptor signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HEPylated G-CSF: Drug with Safer, Enhanced Delivery for Neutropenia Treatment
-
批准号:8121665
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2011
-
负责人:PAUL L DEANGELIS
-
依托单位:
COMPUTATIONAL MODELING OF INTERACTIONS BETWEEN HYALURONAN AND LINK MODULES
-
批准号:7956112
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2009
-
负责人:PAUL L DEANGELIS
-
依托单位:
COMPUTATIONAL MODELING OF INTERACTIONS BETWEEN HYALURONAN AND LINK MODULES
-
批准号:7723175
-
项目类别:
-
资助金额:$0.05万
-
财政年份:2008
-
负责人:PAUL L DEANGELIS
-
依托单位:
COMPUTATIONAL MODELING OF INTERACTIONS BETWEEN HYALURONAN AND LINK MODULES
-
批准号:7601409
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2007
-
负责人:PAUL L DEANGELIS
-
依托单位:
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs
-
批准号:8436566
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2000
-
负责人:PAUL L DEANGELIS
-
依托单位:
Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs
-
批准号:8786583
-
项目类别:
-
资助金额:$38.34万
-
财政年份:2000
-
负责人:PAUL L DEANGELIS
-
依托单位:
EUKARYOTIC HYALURONAN SYNTHASES
-
批准号:6019366
-
项目类别:
-
资助金额:$14.47万
-
财政年份:1997
-
负责人:PAUL L DEANGELIS
-
依托单位:
EUKARYOTIC HYALURONAN SYNTHASES
-
批准号:2734840
-
项目类别:
-
资助金额:$14.06万
-
财政年份:1997
-
负责人:PAUL L DEANGELIS
-
依托单位:
EUKARYOTIC HYALURONAN SYNTHASES
-
批准号:2396085
-
项目类别:
-
资助金额:$14.99万
-
财政年份:1997
-
负责人:PAUL L DEANGELIS
-
依托单位:
EUKARYOTIC HYALURONAN SYNTHASES
-
批准号:6181279
-
项目类别:
-
资助金额:$14.9万
-
财政年份:1997
-
负责人:PAUL L DEANGELIS
-
依托单位:
EUKARYOTIC HYALURONAN SYNTHASES
-
批准号:6446402
-
项目类别:
-
资助金额:$4.99万
-
财政年份:1997
-
负责人:PAUL L DEANGELIS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: